Login
$CATX
$0.94 +$0.01 (1.32%) After hours

$CATX 4 SEC Filings

Filed On Filing
16 Nov 2026 Form 4: Morich Frank, Director

Bought 15,000 shares ($15K)

16 Nov 2026 Form 4: Williamson Robert F Iii, Director

Bought 24,898 shares ($20.9K)

16 Nov 2026 Form 4: Woods Lori A, Director

Bought 23,750 shares ($20K)

13 Nov 2026 Form 4: Puhlmann Markus, Chief Medical Officer

Bought 6,000 shares ($4.98K) · Bought 35,000 shares ($29.6K)

12 Nov 2026 Form 4: Spoor Johan M., Director

Bought 47,000 shares ($37.9K)

08 Sep 2026 Form 4: Lantheus Alpha Therapy, Llc, 10% owner and 1 other

Sold 80,783 shares ($251K) · Sold 167,149 shares ($526K)

04 Sep 2026 Form 4: Lantheus Alpha Therapy, Llc, 10% owner and 1 other

Sold 42,129 shares ($131K)

04 Sep 2026 Form 4: Lantheus Alpha Therapy, Llc, 10% owner

Sold 78,145 shares ($246K) · Sold 35,769 shares ($112K)

03 Sep 2026 Form 4: Lantheus Holdings, Inc., 10% owner

Sold 35,769 shares ($112K)

02 Sep 2026 Form 4: Lantheus Holdings, Inc., 10% owner

Sold 78,145 shares ($246K)

04 Mar 2026 Form 4: Henson Heidi, Director

Granted 50,000 Stock option (right to buy)

04 Mar 2026 Form 4: Martinez Maria E, Director

Granted 50,000 Stock option (right to buy)

04 Mar 2026 Form 4: Morich Frank, Director

Granted 50,000 Stock option (right to buy)

04 Mar 2026 Form 4: Williamson Robert F Iii, Director

Granted 50,000 Stock option (right to buy)

04 Mar 2026 Form 4: Woods Lori A, Director

Granted 50,000 Stock option (right to buy)

04 Mar 2026 Form 4: Spoor Johan M., Director

Granted 735,000 Stock option (right to buy)

04 Mar 2026 Form 4: Hunt Jonathan Robert, Chief Accounting Officer

Granted 90,000 Stock option (right to buy)

04 Mar 2026 Form 4: Puhlmann Markus, Chief Medical Officer

Granted 150,000 Stock option (right to buy)

17 Nov 2025 Form 4: Hunt Jonathan Robert, Chief Accounting Officer

Bought 11,000 shares ($22.3K)

14 Nov 2025 Form 4: Williamson Robert F Iii, Director

Bought 9,498 shares ($19.9K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support